Socrodeucitinib significantly reduced PASI scores at 12 weeks of treatment among adults with moderate to severe plaque psoriasis.
One in 5 adults with newly diagnosed moderate to severe plaque psoriasis maintained clear or almost-clear skin a full year ...
Psoriasis Area and Severity Index (PASI) score is the primary instrument used to assess psoriasis severity and determine eligibility for clinical trials. The PASI scoring system assumes fixed adult ...
G2-PASE approximates PASI using routinely captured PGA and BSA, aiming to replace impractical PASI scoring in real-world clinical settings without sacrificing measurement fidelity. Strong performance ...
CHICAGO -- Almost two-thirds of teens with plaque psoriasis saw complete skin clearance after 6 months of treatment with icotrokinra, an investigational oral peptide drug that blocks interleukin-23 ...
Initiating biologic therapy as a first-line systemic treatment for moderate-to-severe plaque psoriasis was associated with better skin clearance, low risks for chronic comorbidities, and improved ...
Behavioral, pharmacological, and surgical weight loss interventions among adults with psoriasis is associated with significant improvements in Psoriasis Area and Severity Index scores compared with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results